UK Parliament Flags Palantir Partnership as Strategic Weakness

On 3 June 2026 the House of Commons Science, Innovation and Technology Committee published a report labeling the UK’s reliance on U.S. data-analytics firm Palantir Technologies an “unacceptable point of weakness.” It highlighted the NHS Federated Data Platform contract, worth £330 million ($444 million) for seven years, as the example.

Palantir's NHS contract has become a test of AI sovereignty

Palantir, which supplies software to U.S. military and immigration agencies, has expanded into British public services via the NHS deal. The committee, led by Dame Chi Onwurah, cited a “clear mismatch with UK values” due to the company’s political ties, including Peter Thiel’s support for former President Donald Trump and Alex Karp’s manifesto urging deference to U.S. interests. Foxglove, a UK non-profit, has campaigned against Palantir’s NHS role; NHS England oversees the platform.

Reuters

The NHS contract is worth £330 million for seven years. The government’s digital-transformation plan aims for £45 billion annual savings, which the committee called “worryingly optimistic.” A 2027 break clause permits termination, and the committee recommends a senior minister to lead the digital strategy.

The Hindu

Palantir chief executive Louis Mosley said the contract was won through an open competitive tender and called the committee’s cancellation suggestion “frankly irresponsible.” Foxglove welcomed the report and urged termination. NHS England said the platform is improving care coordination, speeding cancer diagnosis, and increasing patient throughput. The Department of Health and Social Care gave no comment.

Reuters

Committee members warned that vendor lock-in could raise costs, degrade service quality, give a foreign supplier leverage over public services, and risk decisions made abroad undermining UK policy goals, raising concerns about handling sensitive health data.

Palantir's NHS contract has become a test of AI sovereignty

The committee’s security-focused assessment contrasts with NHS England’s claim of clinical benefits, and no government response was recorded, leaving the likelihood of invoking the 2027 break clause uncertain.

Reuters

• “That could bring public services and our economy to a halt.” — Dame Chi Onwurah, Chair, Science, Innovation and Technology Committee

Wired Magazine

• “It is frankly irresponsible to call for its cancellation.” — Louis Mosley, CEO, Palantir UK

Reuters

• “MPs across parties, NHS staff, and a growing swathe of the public are united in their belief that a firm like this should have no part in our public services.” — Foxglove statement

Reuters

• “The government’s … ambitions could be derailed at any time by a decision taken outside our shores based on the narrow interests of a foreign commercial or state actor.” — Committee report

The Hindu

The report frames reliance on Palantir as a digital-sovereignty issue, suggesting that entrenched foreign technology could limit UK policy autonomy and erode public trust in data handling.

Palantir's NHS contract has become a test of AI sovereignty

The committee urges activation of the 2027 break clause, development of a domestic or in-house alternative, and appointment of a senior minister to oversee the digital transformation strategy.

Reuters